HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul A DiSilvestro Selected Research

Proteasome Inhibitors

1/2017A phase I pharmacokinetic study of intraperitoneal bortezomib and carboplatin in patients with persistent or recurrent ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul A DiSilvestro Research Topics

Disease

14Ovarian Neoplasms (Ovarian Cancer)
10/2020 - 09/2002
10Carcinoma (Carcinomatosis)
04/2024 - 12/2006
9Neoplasms (Cancer)
10/2020 - 01/2007
6Ovarian Epithelial Carcinoma
08/2020 - 02/2016
4Endometrial Neoplasms (Endometrial Cancer)
01/2022 - 01/2010
4Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2016 - 12/2006
3Disease Progression
02/2016 - 09/2002
2Nausea
04/2024 - 12/2019
2Carcinosarcoma
01/2022 - 06/2014
2Neoplasm Metastasis (Metastasis)
11/2021 - 01/2020
2Thrombocytopenia (Thrombopenia)
12/2019 - 02/2016
2Anemia
12/2019 - 02/2016
2Carcinogenesis
04/2019 - 01/2019
2Neutropenia
02/2016 - 02/2016
1Pain (Aches)
04/2024
1Vomiting
04/2024
1Neoplasm Micrometastasis
11/2021
1Vulvar Neoplasms (Vulvar Cancer)
11/2021
1Body Weight (Weight, Body)
10/2020
1Breast Neoplasms (Breast Cancer)
02/2020
1Fatigue
12/2019
1Hypertension (High Blood Pressure)
02/2016
1Fallopian Tube Neoplasms
02/2016
1Sepsis (Septicemia)
02/2016
1Microsatellite Instability
01/2016
1Flatulence
08/2002

Drug/Important Bio-Agent (IBA)

10Carboplatin (JM8)FDA LinkGeneric
01/2022 - 09/2002
10Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 09/2002
5Cisplatin (Platino)FDA LinkGeneric
01/2022 - 12/2006
5Biomarkers (Surrogate Marker)IBA
01/2020 - 11/2016
5Proteins (Proteins, Gene)FDA Link
05/2019 - 01/2016
4Bevacizumab (Avastin)FDA Link
10/2020 - 02/2016
4PlatinumIBA
01/2019 - 01/2007
2veliparibIBA
12/2019 - 02/2016
22- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA
05/2019 - 01/2019
2liposomal doxorubicin (Doxil)FDA Link
02/2016 - 01/2007
1pembrolizumabIBA
04/2024
1ElectrolytesIBA
04/2024
1epacadostatIBA
04/2024
1IfosfamideFDA LinkGeneric
01/2022
1TubulinIBA
10/2020
1fosbretabulin (combretastatin A4)IBA
10/2020
1Angiogenesis InhibitorsIBA
10/2020
1Interleukin-8 (Interleukin 8)IBA
01/2020
1Adenosine Diphosphate Ribose (ADP-Ribose)IBA
12/2019
1Adenosine Diphosphate (ADP)IBA
12/2019
1Glycoproteins (Glycoprotein)IBA
01/2019
1Proteasome InhibitorsIBA
01/2017
1Fibronectins (Fibronectin)IBA
01/2017
1Bortezomib (Velcade)FDA Link
01/2017
11-dodecylpyridoxal (PLD)IBA
02/2016
1Reactive Oxygen Species (Oxygen Radicals)IBA
04/2015
1pazopanibFDA Link
06/2014
1Tirapazamine (SR 4233)IBA
02/2014
1Docetaxel (Taxotere)FDA Link
12/2012
1Trastuzumab (Herceptin)FDA Link
01/2010

Therapy/Procedure

11Drug Therapy (Chemotherapy)
01/2022 - 09/2002
9Therapeutics
10/2020 - 09/2002
5Radiotherapy
11/2021 - 12/2006
4Chemoradiotherapy
01/2022 - 02/2014
2Combination Drug Therapy (Combination Chemotherapy)
01/2019 - 01/2007
1Lymph Node Excision (Lymph Node Dissection)
11/2021
1Salpingo-oophorectomy
02/2020
1Induction Chemotherapy
12/2019
1Adjuvant Chemotherapy
01/2019
1Brachytherapy
01/2019
1Consolidation Chemotherapy
01/2007
1Length of Stay
08/2002